CONTROLLED RELEASE 25-HYDROXYVITAMIN D

The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	White, Jay A, Bishop, Charles W, Crawford, Keith H, Petkovich, P. Martin, Messner, Eric J, Tabash, Samir P, Agudoawu, Sammy A
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides a pharmaceutical composition comprising an oral formulation of 25-hydroxyvitamin D3 for use in a method of treatment of secondary hyperparathyroidism in a human patient having chronic kidney disease. The method of treatment comprises administering the composition to the patient and the patient is treated without causing supraphysiological surges in blood levels of 25-hydroxyvitamin D3.